APL is a subtype of AML characterized by a specific chromosomal translocation, t(15;17) that encodes a fusion of the proteins of promyelocytic leukaemia (PML) and retinoic acid receptor-α (RARα)26. This evidence concerns the gene PML and acute myeloid leukemia.